Osteoporosis: all 1,675 studies
Page 16 of 17. Open to participants first (211), then studies with results posted, then the rest; newest registration first within each.
- A Safety and Efficacy Study for Treatment of Painful Vertebral Compression Fractures Caused by OsteoporosisStatus unknownNCT00290862Not applicable
- A Randomized Controlled Trial of a Bone Density Decision AideTerminatedNCT00285168
- Potassium Citrate to Prevent Age Related Bone LossCompletedNCT00282126Not applicable
- Secondary Prevention of Osteoporotic Fractures in Residents of Long-Term Care FacilitiesCompletedNCT00280943Phase 2/3
- Alendronate Osteoporosis StudyCompletedNCT00277251Phase 2/3
- The Effectiveness of Individualised Bone Density Feedback and Osteoporosis Education in Premenopausal WomenCompletedNCT00273260Phase 2
- Impact of Oral Ibandronate 150 mg Monthly on Structural Properties of Bone in Postmenopausal Osteoporosis (SPIMOS-3D)CompletedNCT00271713Phase 4
- Bone Physiology & Mechanics in Osteomyoplasty Amputation RehabilitationTerminatedNCT00271362Not applicable
- IMPACT Study (Improving Measurements of Persistence on "ACtonel" Treatment)CompletedNCT00268632Phase 3
- Can Alendronate Suppress Calcification and Improve Bone Density in Chronic Peritoneal Dialysis Patients?CompletedNCT00261625Phase 4
- The Nitrate and Bone Study: Effects of Nitrates on OsteoporosisCompletedNCT00252421Phase 3
- Danish Osteoporosis Prevention StudyCompletedNCT00252408Phase 4
- Isoflavones for Promoting Calcium Absorption and Preventing Bone Loss in Post Menopausal WomenCompletedNCT00244907Phase 1
- Soy, Bone and Health in College FemalesCompletedNCT00244478Not applicable
- Teriparatide and Strontium Ranelate Head-To-Head Comparison TrialCompletedNCT00239629Phase 4
- Study Evaluating Bazedoxifene Dose-Response in Japanese Patients With Postmenopausal Osteoporosis.CompletedNCT00238745Phase 2
- Cancer and Osteoporosis Research With Alendronate and Lupron (C.O.R.A.L )TerminatedNCT00236002Phase 3
- VERTOS-II. Percutaneous Vertebroplasty Versus Conservative TherapyCompletedNCT00232466Not applicable
- Osteoporosis and Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00231127
- Aquatic Verses Land Exercise to Decrease Fall RiskCompletedNCT00227071Not applicable
- Optimal Management of Women With Wrist FracturesCompletedNCT00226031Not applicable
- Improving Quality With Outpatient Decision SupportCompletedNCT00225628Not applicable
- Osteoporosis and Colles FractureTerminatedNCT00225004
- Osteoporosis SchoolCompletedNCT00224991Not applicable
- 3-Week Parathyroid Hormone-related Protein (PTHrP) Dose Escalation Study in Post-Menopausal WomenCompletedNCT00222872Phase 1
- Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in JapanCompletedNCT00212719Phase 3
- Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in JapanCompletedNCT00212667Phase 3
- Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in JapanCompletedNCT00212628Phase 3
- FREE Study - Fracture Reduction EvaluationCompletedNCT00211211Phase 4
- Network Osteoporosis StudyStatus unknownNCT00209469Phase 2/3
- Vitamin D Administration in the Nursing HomeCompletedNCT00204919Not applicable
- Effect of Exercise Training and Soy-based Nutritional Supplementation on Prevention of OsteoporosisCompletedNCT00204425Phase 3
- Exercise and Flax-Based Nutritional Supplementation for Lowering CholesterolCompletedNCT00204412Phase 3
- Percutaneous Vertebroplasty Versus Conservative Treatment of PainCompletedNCT00203554Not applicable
- Safety and Efficacy Study of Bugusan (BGS)to Treat Osteoporosis.Status unknownNCT00202956Phase 2
- Bone Effects of Teriparatide Following AlendronateCompletedNCT00191893Phase 3
- Clinical Trial of Teriparatide in JapanCompletedNCT00191867Phase 2
- Compliance and Acceptance of Teriparatide Injection in Severely Osteoporotic PatientsCompletedNCT00191802Phase 3
- 2-Year Therapy With Teriparatide vs 1-yr Therapy Followed by 1-Year of Raloxifene or Calcium/Vit D in Severe Postmenopausal OsteoporosisCompletedNCT00191425Phase 4
- Teriparatide Use in Hip Replaced SubjectsCompletedNCT00191321Phase 3
- Effect of Vitamin K on Age-Related Bone Loss and Vascular CalcificationCompletedNCT00183001Phase 3
- Testosterone Effects on Bone and FrailtyCompletedNCT00182871Phase 4
- An Open Clinical Trial to Assess the Influence of Newly Prescribed Aminobiphosphonates on Arterial StiffnessWithdrawnNCT00180232
- Prevention of Osteoporosis in Men With Prostate Cancer on Androgen Deprivation Therapy (POP Study)CompletedNCT00177619Phase 3
- "PTHrP(1-36) IV Dose Escalation Study"WithdrawnNCT00177411Phase 1
- Bone Mineral Density and Cancer Recurrence in Patients With Early Stage Prostate CancerCompletedNCT00176579
- Controlled Trial to Increase Detection and Treatment of Osteoporosis in Older Patients With a Wrist FractureCompletedNCT00175214Not applicable
- Randomized Trial of Osteoporosis Intervention Strategies in Hip Fracture PatientsCompletedNCT00175175Not applicable
- What is the Best Policy to Prevent Osteoporotic Fracture?WithdrawnNCT00173693Not applicable
- Dynamic Magnetic Resonance (MR) Study in Evaluating the Vertebral Bone Marrow Perfusion and Its Related ResearchCompletedNCT00172224
- Calcium Supplementation in Postmenopausal WomenCompletedNCT00172172Phase 3
- Open Label Extension Study of PREOSCompletedNCT00172133Phase 3
- Open Label ExtensionCompletedNCT00172120Phase 3
- A Study to Assess the Safety and Efficacy of 3 Doses of ALX1-11 (50, 75, and 100µg) in the Treatment of Postmenopausal OsteoporosisCompletedNCT00172107Phase 2
- TOP: Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal OsteoporosisCompletedNCT00172081Phase 3
- The Use of Zoledronic Acid in Men on Androgen Deprivation Therapy for Prostate Cancer With Preexisting OsteoporosisCompletedNCT00171639Phase 3
- Efficacy and Safety of AAE581 in Postmenopausal Women With Osteopenia/Osteoporosis.CompletedNCT00170911Phase 2
- Bone Density and Serum Testosterone in Male Methadone Maintained PatientsCompletedNCT00170339
- Influence of Alfacalcidol on Falls in Osteopenic/Osteoporotic Postmenopausal Women (ALFA Study)CompletedNCT00168909Phase 4
- Randomized, Open, Parallel, Active Controlled Study on Fracture Prevention in Antiosteoporosis Treatment (OF Study)CompletedNCT00165607Phase 4
- Comparison of Raloxifene and Lasofoxifene - A Randomized, Blinded Study of These Drugs and Placebo on Bone LossCompletedNCT00163137Phase 3
- Study of Alendronate to Prevent and Treat Osteoporosis in Cystic Fibrosis PatientsCompletedNCT00157690Phase 4
- Pseudodrynaria Coronana (Wall) ChingCompletedNCT00155675Phase 1
- Davallia Divaricata BL: The Use of Traditional Chinese Native Medicine for OsteoporosisStatus unknownNCT00154609Phase 1
- Strategies Targeting Osteoporosis to Prevent Recurrent FracturesCompletedNCT00152321Not applicable
- Risedronate for the Prevention of Osteoporosis in People With Spinal Cord Injury.CompletedNCT00150696Phase 3
- Effectiveness of Vibration and Standing Versus Standing Alone for the Treatment of Osteoporosis for People With Spinal Cord Injury.CompletedNCT00150683Not applicable
- A Study To Assess the Quality and Strength of Bone in Women Participants With Osteoporosis Taking Oral Ibandronate Versus PlaceboCompletedNCT00148915Phase 4
- Bone Mineral Density (BMD) in HIV InfectionTerminatedNCT00146094Not applicable
- Comparison of Osteoporosis Disease Management Strategies (0000-039)CompletedNCT00145080Not applicable
- Osteoporosis Disease Management Demonstration Project (0000-040)CompletedNCT00145067Not applicable
- A New Active Vitamin D, ED-71 for OsteoporosisCompletedNCT00144456Phase 3
- Dose Response Study of Lasofoxifene in Postmenopausal Women With Osteoporosis - Japanese Asian Dose EvaluationCompletedNCT00143273Phase 2
- Postmenopausal Evaluation and Risk-reduction With Lasofoxifene (PEARL)CompletedNCT00141323Phase 3
- Improving Management of Patients at High Risk for Osteoporotic Fractures (0000-038)CompletedNCT00139438Not applicable
- Osteoporosis Disease Management Demonstration Project (0000-037)CompletedNCT00139425Not applicable
- Prevention of Glucocorticoid-Induced Osteoporosis in Rheumatic Diseases: Alendronate Versus Alfacalcidol.CompletedNCT00138983Phase 3
- Risedronate for the Treatment of Osteoporosis for People With Spinal Cord InjuryCompletedNCT00138866Phase 3
- Trial of Osteoporosis Intervention Strategies in Hip Fracture PatientsCompletedNCT00136058Phase 3
- OPTAMISE: Clinical Effectiveness of Teriparatide After Alendronate or Risedronate Therapy in Osteoporotic Postmenopausal WomenCompletedNCT00130403Phase 4
- Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation TherapyCompletedNCT00129142Phase 3
- Study to Determine the Prevalence of Osteoporosis in Patients With Advanced Prostate Cancer Treated With Hormonal ManipulationCompletedNCT00124410
- Efficacy of Alendronate Versus Placebo in the Treatment of HIV-associated Osteoporosis (ANRS120)CompletedNCT00120757Phase 3
- Atorvastatin (Lipitor) to Prevent Bone PainCompletedNCT00120133Not applicable
- The Prevention of Osteoporosis in Premenopausal and Newly Postmenopausal (Up to 8 Years) Women With Breast Cancer Following Chemotherapy (REBBeCA Study)CompletedNCT00118508Not applicable
- The Effect of Zoledronic Acid on Bone Density in Liver Transplant PatientsCompletedNCT00114556Phase 4
- Letrozole With or Without Zoledronate in Treating Healthy Postmenopausal Women With High Breast DensityCompletedNCT00114270Not applicable
- Zoledronate in Preventing Bone Loss in Postmenopausal Women Who Are Receiving Letrozole for Stage I, Stage II, or Stage IIIA Breast CancerCompletedNCT00107263Phase 3
- Bisphosphonate Therapy for HIV-Infected Adults With Decreased Bone Mineral DensityStatus unknownNCT00102908Phase 2
- Efficacy and Safety of Zoledronic Acid in the Prevention and Treatment of Corticosteroid Induced OsteoporosisCompletedNCT00100620Phase 3
- Safety and Efficacy of AAE581 in Postmenopausal Women With OsteoporosisCompletedNCT00100607Phase 2
- A Study of the Clinical Safety, Tolerability, and Efficacy of Zoledronic Acid Compared to an Oral BisphosphonateCompletedNCT00100555Phase 3
- Efficacy and Safety of Zoledronic Acid for the Treatment of Osteoporosis in MenCompletedNCT00097825Phase 3
- Switching Osteoporosis Patients Currently on Oral Bisphosphonate to Zoledronic AcidCompletedNCT00097812Phase 3
- A Study of MK0217A and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227)CompletedNCT00092079Phase 3
- A Study to Evaluate the Safety, Tolerability, and Efficacy of an Investigational Drug and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227)CompletedNCT00092066Phase 3
- Study of Investigational Drug in Osteoporosis (MK-0217-908)CompletedNCT00092053Phase 3
- A Study and 12 Month Extension to Evaluate Two Investigational Drugs in Postmenopausal Women With Osteoporosis (MK-0217-907)CompletedNCT00092040Phase 3
- A Study to Evaluate the Safety and Tolerability of MK0217 in Women (0217-219)CompletedNCT00092027Phase 3
- A Study to Evaluate and Compare Alendronate and Risedronate on Bone Mineral Density in Women With Postmenopausal Osteoporosis (MK-0217-211)CompletedNCT00092014Phase 3